首页> 中文期刊> 《世界中医药》 >中医药对高血压前期血压影响的 Meta 分析

中医药对高血压前期血压影响的 Meta 分析

         

摘要

目的:系统评价中医药对高血压前期血压的影响。方法:计算机检索国内外关于中医药干预高血压前期的临床随机对照试验,使用I2评估各研究之间的异质性,并用RevMan 5.2.0软件进行Meta分析。结果:共纳入8篇文献,1005例受试者。 Meta分析结果提示,与对照组相比,试验组在降低收缩压( WMD:-3.65;95%CI:-5.35~-1.94;I2∶87%)及舒张压( WMD:-2.58;95%CI:-4.30~-0.86;I2∶93%)方面均优于对照组,2组间的差异具有统计学意义( P<0.01)。结论:在生活方式干预的基础上,加用中医药干预有助于进一步降低血压水平。%Objective:To evaluate the effect of Chinese herbal medicine on blood pressure in pre-hypertensive cases .Methods:Domestic and international databases were searched for relevant randomized controlled trials (RCTs)which investigated the effect of Chinese herbal medicine on blood pressure in pre-hypertensive cases .Heterogeneity of cross-studies was assessed ,using I2.All me-ta-analyses were conducted through RevMan 5.2.0.Results:Eight RCTs involving 1005 subjects were selected .Meta-analysis dem-onstrated that the test group reduces the level of both systolic blood pressure (WMD:-3.65;95%CI:-5.35~-1.94;P<0.01, I2:87%) and diastolic blood pressure ( WMD:-2.58;95%CI:-4.30~-0.86;P<0.01;I2:93%) ,compared with the control group.The difference was statistically significant .Conclusion:Basing on lifestyle intervention ,Chinese herbal medicine helped re-ducing the level of blood pressure .

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号